GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Seikagaku Corp (TSE:4548) » Definitions » Institutional Ownership

Seikagaku (TSE:4548) Institutional Ownership : 12.17% (As of Jun. 10, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Seikagaku Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Seikagaku's institutional ownership is 12.17%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Seikagaku's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Seikagaku's Float Percentage Of Total Shares Outstanding is 0.00%.


Seikagaku Institutional Ownership Historical Data

The historical data trend for Seikagaku's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seikagaku Institutional Ownership Chart

Seikagaku Historical Data

The historical data trend for Seikagaku can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 12.88 12.77 12.33 11.98 12.13 12.13 12.13 12.16 12.18 12.17

Seikagaku Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Seikagaku (TSE:4548) Business Description

Traded in Other Exchanges
N/A
Address
Marunouchi Center Building 10 Floor, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-0005
Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.

Seikagaku (TSE:4548) Headlines

No Headlines